Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries
about
Induction of apoptosis in vascular cells by plasminogen activator inhibitor-1 and high molecular weight kininogen correlates with their anti-adhesive propertiesGenetics of ischaemic stroke in young adultsRole of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseasesHMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statinsCardiovascular and inflammatory effects of intratracheally instilled ambient dust from Augsburg, Germany, in spontaneously hypertensive rats (SHRs)Down-regulation of plasminogen activator inhibitor 1 expression promotes myocardial neovascularization by bone marrow progenitorsGenome-wide association study for circulating levels of PAI-1 provides novel insights into its regulationTransgenic over-expression of plasminogen activator inhibitor-1 results in age-dependent and gender-specific increases in bone strength and mineralization.Epistatic interactions in genetic regulation of t-PA and PAI-1 levels in a Ghanaian population.Attenuation of neointimal vascular smooth muscle cellularity in atheroma by plasminogen activator inhibitor type 1 (PAI-1).Seronegative antiphospholipid syndrome associated with plasminogen activator inhibitor.Leptin upregulates the expression of plasminogen activator inhibitor-1 in human vascular endothelial cells.Plasminogen activator inhibitor-1 is an aggregate response factor with pleiotropic effects on cell signaling in vascular disease and the tumor microenvironment.Plasminogen activator inhibitor-1 is a major stress-regulated gene: implications for stress-induced thrombosis in aged individuals.Relationship of metabolic syndrome and its components with -844 G/A and HindIII C/G PAI-1 gene polymorphisms in Mexican children.Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditionsPeptide-mediated inactivation of recombinant and platelet plasminogen activator inhibitor-1 in vitro.Plasminogen activator inhibitor-1 gene polymorphism in Iranian Azeri Turkish patients with FMF disease and its association with amyloidosis.Gene polymorphisms of the haemostatic system and the risk of arterial thrombotic disease.Electroacupuncture improves cerebral blood flow and attenuates moderate ischemic injury via Angiotensin II its receptors-mediated mechanism in rats.Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction.The effects of postmenopausal hormone replacement therapy on hemostatic variables: a meta-analysis of 46 studies.Plasminogen activator inhibitor-1: physiologic role, regulation, and the influence of common pharmacologic agents.SIRT1-mediated epigenetic downregulation of plasminogen activator inhibitor-1 prevents vascular endothelial replicative senescenceUpdate on the Serum Biomarkers and Genetic Factors Associated with Safety and Efficacy of rt-PA Treatment in Acute Stroke Patients.A small molecule PAI-1 functional inhibitor attenuates neointimal hyperplasia and vascular smooth muscle cell survival by promoting PAI-1 cleavagePAI-1 4G/5G polymorphism and coronary artery disease risk: a meta-analysis.Pharmacologic blockade of the renin-angiotensin system: vascular benefits beyond commonly understood pharmacologic actions.Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis.Modulation of NF-κB-dependent gene transcription using programmable DNA minor groove bindersExpression of fibrinolytic genes in atherosclerotic abdominal aortic aneurysm wall. A possible mechanism for aneurysm expansion.Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse.Chemical Antagonists of Plasminogen Activator Inhibitor-1: Mechanisms of Action and Therapeutic Potential in Vascular Disease.Patterns of expression of fibrinolytic genes and matrix metalloproteinase-9 in dissecting aortic aneurysms.Endotoxin stimulates expression of the murine urokinase receptor gene in vivoAtheromatous plaque macrophages produce plasminogen activator inhibitor type-1 and stimulate its production by endothelial cells and vascular smooth muscle cellsPlasminogen activator inhibitor-1 4G/5G polymorphism is associated with metabolic syndrome parameters in Malaysian subjects.Biomarkers of obesity and subsequent cardiovascular eventsLeptin locally synthesized in carotid atherosclerotic plaques could be associated with lesion instability and cerebral emboliPlasminogen deficiency accelerates vessel wall disease in mice predisposed to atherosclerosis.
P2860
Q24300523-D825A2DF-6912-494E-A141-14682F6091D9Q26775633-2C34D84D-31A9-4D13-B540-8B32F0CF49E6Q27008359-4008B1B5-9931-4F0C-ABB2-9CE4427D4297Q28344912-58C7710D-549B-423B-9651-5B7F0A0502FBQ28383982-FF9658BF-7FFA-4E77-BC63-E4955AD5C261Q28565062-15A89515-756E-49B9-958F-6FD9D5BB5D06Q30415902-91FBD8F7-DD65-48C6-8485-2EF88501F6EEQ30442725-3CDE13B1-346C-4788-8DC4-5CB92EB2CA3EQ30999425-38D36226-58D0-4B8A-BFAB-342B53C4F8A6Q33204826-2F6373AD-995C-4A5A-AB35-AB6570EC3D7BQ33491105-35DEE867-9ED4-4C25-9491-D58619EA3EBCQ33700633-F67E8484-8E76-4654-85D6-70B59015613DQ33812093-567F75FD-809C-4E73-B7BD-A88BF28E5E33Q33894605-F41ACED5-7DB0-4A91-9E0C-D92FDE22534FQ34212957-83BA9F6E-15C3-4ADD-B92D-B4ED30DD31C3Q34217461-CC37B274-01BB-4F77-8B32-17B3A92BFD3AQ34220031-4756F84C-BEC6-4451-8D86-76E6C27E98F7Q34439639-A62BFD20-6D18-403A-8651-50C50FAE9D51Q34459073-7C10678C-395B-44C4-8128-778C178671A2Q34544159-405280B7-4B49-4ABA-A775-55766DAA485AQ34545496-F56DA051-8F91-413A-BADA-E40C80B774D6Q34978893-EB6221ED-D288-4189-9516-E9B9E32BBC4FQ34986710-37E58AAF-FF5C-45D9-B369-1A154C3995A9Q35093088-5CEC2839-4168-4771-B14A-800F2FCC2037Q35109940-028AEB9D-F863-4575-B787-FC4847D62978Q35181410-D8CD3BAE-2B3A-45C3-BA6E-A7B9F0320813Q35479955-43A36B00-3A9A-4370-B5C5-D4A599F7CB8DQ35549761-A8FEBAAA-BD71-42FC-A8B5-1A6ACD960A88Q35552418-656B6F9F-79AE-4D2D-8FD1-EBE176C150DFQ35709298-C25F2230-301C-4227-B9EC-5039B8EE6CD1Q35751580-42AD5897-EED0-4E79-A76B-CB2EF55E9DDBQ35763567-0F26F0BC-A448-4687-B501-E7B8C501876FQ35764595-8294397D-1B74-411C-AAAC-91B520007EC1Q35765078-9261DB70-0B5A-4C94-8BB9-D1B72406A386Q35798348-F923FAFD-A2E3-4713-B1B2-6D619BDE86E1Q35833573-B1F3A7BC-CDA1-45AD-A45F-E57B9D39CDE0Q35906917-398E17DF-D36E-4BD7-9E4F-3899129FBC75Q36381096-E6FDE096-E11E-4F16-9057-F59F3E537A61Q36522619-B8EC8D16-85B5-44F3-AEC4-14BDFFEA61F6Q36586261-3E531A61-633F-4DEE-928F-530D61D59724
P2860
Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 1992
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Increased type 1 plasminogen a ...... atherosclerotic human arteries
@en
Increased type 1 plasminogen a ...... therosclerotic human arteries.
@nl
type
label
Increased type 1 plasminogen a ...... atherosclerotic human arteries
@en
Increased type 1 plasminogen a ...... therosclerotic human arteries.
@nl
prefLabel
Increased type 1 plasminogen a ...... atherosclerotic human arteries
@en
Increased type 1 plasminogen a ...... therosclerotic human arteries.
@nl
P2093
P2860
P356
P1476
Increased type 1 plasminogen a ...... atherosclerotic human arteries
@en
P2093
D J Loskutoff
E F Bernstein
G M Bordin
J Schneiderman
M R Keeton
M S Sawdey
R B Dilley
P2860
P304
P356
10.1073/PNAS.89.15.6998
P407
P577
1992-08-01T00:00:00Z